Seer announces new data at HUPO 2025, showcasing proteomics in disease research.

Seer, Inc. is showcasing its Proteograph Product Suite at the HUPO World Congress 2025, demonstrating how deep, scalable proteomics is transforming the study of human disease. The company's technology is featured in over a dozen scientific presentations, highlighting its use in cardiovascular, oncology, and aging biology research. Seer's Proteograph Product Suite is enabling scientists to translate complex biological signatures into actionable understanding, bringing proteomics to the forefront of translational and population-scale research.